Literature DB >> 9136850

Inhibitory effect of bile salts on gallbladder smooth muscle contractility in the guinea pig in vitro.

Q W Xu1, S M Freedman, E A Shaffer.   

Abstract

BACKGROUND & AIMS: Impaired gallbladder emptying occurs in patients undergoing bile salt therapy for cholesterol gallstone dissolution and in patients with cirrhosis who have elevated serum bile salt concentrations. To determine if bile salts directly inhibit gallbladder contractility, isometric contraction of the guinea pig gallbladder was examined in vitro.
METHODS: Contractile responses to cholecystokinin (CCK), bethanechol, KCI, and field stimulation were constructed alone and in the presence of selected bile salts: taurodeoxycholate (TDC), taurochenodeoxycholate, taurocholate, and tauroursodeoxycholate (TUDC).
RESULTS: More hydrophobic bile salts, such as TDC (as low as 5 micromol/L), concentration-dependently depressed (P < 0.05) both CCK- and field stimulation-induced gallbladder contractions. More hydrophilic bile salts, such as TUDC, only caused a modest depression up to a concentration of 500 micromol/L. When 5 or 50 micromol/L of TUDC was added to the organ bath before the application of equalmolar TDC, the TDC-induced impaired gallbladder contractility was reversed. Thus, this inhibitory effect on gallbladder contraction depended on the hydrophobicity of bile salts and was also specific for certain stimuli such as CCK and field stimulation (mediated by cholinergic nerves, being abolished by atropine and tetrodotoxin).
CONCLUSIONS: Such direct bile salt inhibition of CCK- and cholinergic nerve-induced gallbladder contraction may contribute to the deteriorating gallbladder emptying in patients undergoing bile salt therapy for stone dissolution and in cirrhotic patients who are at risk for gallstone formation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9136850     DOI: 10.1016/s0016-5085(97)70053-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels.

Authors:  Brigitte Lavoie; Onesmo B Balemba; Cody Godfrey; Conall A Watson; Galya Vassileva; Carlos U Corvera; Mark T Nelson; Gary M Mawe
Journal:  J Physiol       Date:  2010-07-12       Impact factor: 5.182

2.  Autonomic dysfunction and cholelithiasis in patients with cirrhosis.

Authors:  A Chawla; L Puthumana; P J Thuluvath
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

3.  Deoxycholic acid inhibits pacemaker currents by activating ATP-dependent K+ channels through prostaglandin E2 in interstitial cells of Cajal from the murine small intestine.

Authors:  Jae Yeoul Jun; Seok Choi; In-Youb Chang; Cha Kyung Yoon; Hye-Gwang Jeong; In Deok Kong; Insuk So; Ki Whan Kim; Ho Jin You
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

4.  Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients.

Authors:  A Colecchia; G Mazzella; L Sandri; F Azzaroli; M Magliuolo; P Simoni; M L Bacchi-Reggiani; E Roda; D Festi
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

5.  Altered migrating myoelectrical complex in an animal model of cholesterol gallstone disease: the effect of erythromycin.

Authors:  Q W Xu; R B Scott; D T Tan; E A Shaffer
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

Review 6.  Smooth muscle function and dysfunction in gallbladder disease.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gerard P vanBerge-Henegouwen
Journal:  Curr Gastroenterol Rep       Date:  2004-04

7.  Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones.

Authors:  B J van de Heijning; P C van de Meeberg; P Portincasa; H Doornewaard; F J Hoebers; K J van Erpecum; G P Vanberge-Henegouwen
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

8.  ATP induces guinea pig gallbladder smooth muscle excitability via the P2Y4 receptor and COX-1 activity.

Authors:  Aaron C Bartoo; Mark T Nelson; Gary M Mawe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-24       Impact factor: 4.052

9.  Increased cholinergic contractions of jejunal smooth muscle caused by a high cholesterol diet are prevented by the 5-HT4 agonist--tegaserod.

Authors:  Ronald Mathison; Eldon Shaffer
Journal:  BMC Gastroenterol       Date:  2006-02-23       Impact factor: 3.067

10.  Ultrasonographic study of gallbladder wall thickness and emptying in cirrhotic patients without gallstones.

Authors:  Massimiliano Loreno; Salvatore Travali; Anna Maria Bucceri; Giuseppe Scalisi; Carla Virgilio; Alfio Brogna
Journal:  Gastroenterol Res Pract       Date:  2009-08-10       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.